Literature DB >> 10376171

Efficacy definitions for migraine studies.

D J Goldstein, W W Offen, M B Moster.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10376171     DOI： 10.1046/j.1468-2982.1999.019004248.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  4 in total

Review 1.  Assessing the efficacy of drugs for the acute treatment of migraine: issues in clinical trial design.

Authors:  Nabih M Ramadan
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Headache Recurrence and Treatment.

Authors:  Sheena K. Aurora; John Dempsey
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

Review 3.  WITHDRAWN: Rizatriptan for acute migraine.

Authors:  A D Oldman; L A Smith; H J McQuay; R A Moore
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

4.  Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

Authors:  Hans-Christoph Diener; Cristina Tassorelli; David W Dodick; Stephen D Silberstein; Richard B Lipton; Messoud Ashina; Werner J Becker; Michel D Ferrari; Peter J Goadsby; Patricia Pozo-Rosich; Shuu-Jiun Wang; Jay Mandrekar
Journal:  Cephalalgia       Date:  2019-02-26       Impact factor: 6.292
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.